CVS Health’s Q4 Earnings Relieve Investor Concerns But Lowers 2024 Profit Guidance Citing Elevated Medical Cost Trends

by

in

On Wednesday, CVS Health Corp (NYSE:CVS) reported fourth-quarter adjusted EPS of $2.12, beating the consensus of $1.99, up from $2.04 a year ago.

Highlighting investors’ concerns about rising healthcare costs for insurers, Bloomberg noted that the worst was feared for CVS Health, like its peers Humana Inc (NYSE:HUM) and UnitedHealth Group Inc (NYSE:UNH).

CVS’s recent results indicate that its insurance unit effectively handled the escalating costs, contributing to positive quarterly performance.

The pharmacy chain reported sales of $93.81 billion, up 11.9% Y/Y, beating …

Full story available on Benzinga.com


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *